"Receptor Radionuclide Therapy With 177Lu-DOTATOC
"Receptor Radionuclide Therapy With 177Lu-DOTATOC
Recruiting · NCT06045260 · Registry updated 2024-08-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| "Receptor Radionuclide Therapy With 177Lu-DOTATOC | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, neoplasm, neuroendocrine neoplasm, paraganglioma, pheochromocytoma, primitive neuroectodermal tumor | Recruiting | Phase 2 | 2024-08-13 | NCT06045260 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | 20 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| AUSL Romagna - Ospedale "M. Bufalini" | Cesena | Italy | 1 |
| IRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" - IRST S.r.l. | Meldola | Italy | 1 |